ONWARD is a brand dedicated to restoring movement, independence, and health in people with spinal cord injury. Their mission is to empower individuals with spinal cord injury to live a fulfilling life in every way that matters to them. With a team of scientists, engineers, and physicians, ONWARD is committed to creating innovative therapies that truly make a difference.

Their flagship product is ARC Therapy™, a groundbreaking approach to spinal cord stimulation. ARC Therapy™ is designed to deliver targeted, programmed stimulation to the spinal cord, enabling individuals with spinal cord injury to regain movement and potentially experience other benefits such as improved bladder control, sexual function, and blood pressure regulation. ONWARD's technology platforms, ARC EX and ARC IM, have received multiple Breakthrough Device Designations from the FDA.

ARC EX is a non-invasive platform consisting of a stimulator and wireless programmer, while ARC IM is an implantable platform controlled by wearable components and a smartwatch. These platforms have shown promising results in clinical studies, with the potential for approval and commercialization in the near future. With a strong foundation in rigorous scientific research and strategic collaborations with leading neuroscience institutions, ONWARD is at the forefront of advancing therapies for spinal cord injury.

Their dedication to improving the lives of those with spinal cord injury is evident in their innovative products and commitment to scientific excellence